A recent antimelanoma experimental study showed that MF59 immunized mice with combined type C CpG ODN-YW002 produced very high levels of IgG2c and IFN-γ, inhibited MUC1-B16 melanoma growth, and prolonged the survival of tumor-bearing mice [12]. Here, MUC1 is linked to melanoma.